<?xml version="1.0" encoding="UTF-8"?>
<p>Specifically, quercetin showed activity against HBV by inhibiting mRNA in HuS-E/2 cells (50 µM: approx. 40%) [
 <xref rid="B72-biomolecules-11-00011" ref-type="bibr">72</xref>] and HBsAg secretion (36.1 ± 7.6%), but not HBeAg, in HepG2 2.2.15 cells (25 μg/mL) [
 <xref rid="B41-biomolecules-11-00011" ref-type="bibr">41</xref>], against murine 
 <italic>betacoronavirus</italic> and mouse hepatitis virus (MHV) CCL9.1 cells at low SI (IC
 <sub>50</sub> 125.0 μg/mL; SI: 0.93) [
 <xref rid="B73-biomolecules-11-00011" ref-type="bibr">73</xref>], against enterovirus 71 (EV71) strain Wuhan/3018/2010 in RD cells (50 μM) [
 <xref rid="B74-biomolecules-11-00011" ref-type="bibr">74</xref>], and against canine distemper virus (CDV) in VERO cells. However, naringenin [
 <xref rid="B75-biomolecules-11-00011" ref-type="bibr">75</xref>], the biosynthetic precursor of naringin, did not [
 <xref rid="B76-biomolecules-11-00011" ref-type="bibr">76</xref>].
</p>
